Diaphragm Pacing Therapy System Market Worth $11.5 Million By 2028

Diaphragm Pacing Therapy System Market Growth & Trends

The global diaphragm pacing therapy system market size is expected to reach USD 11.5 million by 2028, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 4.6% from 2021 to 2028. Some of the factors contributing to the market growth are the upsurge in the prevalence of breathing disorders including sleep apnea, the rise in spinal cord injuries, and amyotrophic lateral sclerosis.

The attributes such as facilitating normal breathing and better speech patterns, movement convenience, ease at eating and drinking, improved sense of smell, and silent functioning of a breathing pacemaker are boosting the adoption of the therapy systems. Moreover, it reduces the dependence on mechanical ventilators and the risk of upper airway infections such as ventilator-associated pneumonia.

The Covid-19 pandemic has further increased the demand for ventilation requirements to cater to the infected patients requiring respiratory care. In April 2020, the diaphragm pacing therapy system by Lungpacer Medical, Inc. received the FDA Emergency Use Authorization (EUA) approval to assist the weaning COVID patients.

 Request a free sample copy or view report summary: Diaphragm Pacing Therapy System Market Report

Diaphragm Pacing Therapy System Market Report Highlights

• The external diaphragm pacemaker segment dominated the market in 2020 owing to the rise in treatment of conditions such as cervical spinal cord injury and congenital central hypoventilation syndrome

• The spinal cord injury segment dominated the market in 2020 in terms of revenue share due to the growing number of spinal cord injuries annually worldwide due to higher rate of accidents, falls, and injuries during sports/recreation activities

• In 2020, North America dominated the market in terms of revenue share. This is due to the growing prevalence of breathing disorders, spinal cord injuries, and amyotrophic lateral sclerosis. Moreover, the increasing consumer disposable income and healthcare expenditure are further expected to support market growth in the region

• In Asia Pacific, the market is expected to witness the fastest CAGR over the forecast period due to the favorable government initiatives, and rising healthcare expenditure

Diaphragm Pacing Therapy System Market Segmentation

Grand View Research has segmented the global diaphragm pacing therapy system market based on product, application, and region:

Diaphragm Pacing Therapy System Product Outlook (Revenue, USD Million, 2016 - 2028)

• External Diaphragm Pacemaker

• Diaphragm Pacemaker

Diaphragm Pacing Therapy System Application Outlook (Revenue, USD Million, 2016 - 2028)

• Spinal Cord Injury

• Amyotrophic Lateral Sclerosis

• Others

Diaphragm Pacing Therapy System Regional Outlook (Revenue, USD Million, 2016 - 2028)

• North America

  • U.S.

  • Canada

• Europe

  • U.K.

  • Germany

  • France

  • Italy

  • Spain

• Asia Pacific

  • Japan

  • China

  • India

  • Australia

• Latin America

  • Brazil

  • Mexico

• Middle East & Africa

  • South Africa

List of Key Players of Diaphragm Pacing Therapy System Market

• Lungpacer Medical Inc.

• Avery Biomedical Devices, Inc.

• Synapse Biomedical

• Atrotech